Reducing Health Disparities Press Releases
Nearly 200 patient advocacy, public health and health care professional organizations sent a letter to the Senate declaring their strong support for the Clinical Trial Modernization Act (S. 4440/H.R. 3521). The bipartisan, bicameral legislation would help remove cost and geographic barriers that keep patients from enrolling and participating in clinical trials. The bill was introduced in the U.S. Senate by Sens. Tim Scott (R-SC) and Mark Warner (D-VA) in April 2026 and in the U.S. House of Representatives in May 2025 by Reps. Raul Ruiz (D-CA) and August Pfluger (R-TX).
WASHINGTON, DC – According to a new American Cancer Society Cancer Action Network (ACS CAN) survey, more than half (53%) of cancer patients and survivors living in rural communities find it difficult to afford their cancer care.
A new bill that would improve access to clinical trials was recently introduced in the U.S. Senate. Sponsored by Senators Tim Scott (R-S.C.) and Mark Warner (D-Va.), the Clinical Trial Modernization Act (S. 4440) would help reduce cost and geographic barriers, making it easier for patients to take part in clinical trials. U.S. Representatives Raul Ruiz (D-Calif.) and August Pfluger (R-Texas) introduced the House version (H.R. 3521) of this legislation in May 2025.
WASHINGTON, DC – 16 de abril de 2026 – La Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) publicó hoy un nuevo informe que muestra el alcance de las desigualdades del cáncer en Estados Unidos y recomienda políticas a nivel local, estatal y federal que pueden ayudar a reducirlas. Desigualdades del cáncer: Un informe gráfico de la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer examina las desigualdades en las pruebas de detección, prevención y detección temprana, desigualdades en la incidencia, mortalidad y supervivencia, así como desigualdades en el acceso a la cobertura de salud.
Cancer survivors and caregivers urge lawmakers to support legislation that will increase access to precision medicine through biomarker testing.
This week, the American Cancer Society Cancer Action Network submitted comments in a letter opposing several policies in the Patient Protection and Affordable Care Act HHS Notice of Benefit and Payment Parameters proposed rule for plan year 2027.
Today, the American Cancer Society Cancer Action Network (ACS CAN) was joined by 24 other organizations in proposing the Health and Human Services Office of Inspector General adopt a new regulatory safe harbor from the Anti-kickback Statute that would allow clinical trial sponsors to financially support patients to offset indirect or non-medical costs associated with clinical trial participation, such as travel, parking and lodging.
ACS CAN presented Medford’s Marina Watanabe with the Young Leader award in recognition of her passionate advocacy and commitment to ending cancer as we know it, for everyone.
MONTGOMERY, Ala. – Patient advocacy groups including the American Cancer Society Cancer Action Network (ACS CAN) and ZERO Prostate Cancer applaud Alabama State Sen.
